283 related articles for article (PubMed ID: 9554413)
21. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
22. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
Hemminki K; Dong C
Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
[TBL] [Abstract][Full Text] [Related]
23. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
24. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
25. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
Crocetti E; Carli P
Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
[TBL] [Abstract][Full Text] [Related]
26. Second neoplasms after invasive and borderline ovarian cancer.
Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
[TBL] [Abstract][Full Text] [Related]
27. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries).
Crocetti E; Guzzinati S; Paci E; Falcini F; Zanetti R; Vercelli M; Rashid I; De Lisi V; Russo A; Vitarelli S; Ferretti S; Mangone L; Cesaraccio R; Tumino R; Pannozzo F
Melanoma Res; 2008 Jun; 18(3):230-4. PubMed ID: 18477899
[TBL] [Abstract][Full Text] [Related]
28. Cancer risk in women with previous breast cancer.
Levi F; Te VC; Randimbison L; La Vecchia C
Ann Oncol; 2003 Jan; 14(1):71-3. PubMed ID: 12488295
[TBL] [Abstract][Full Text] [Related]
29. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.
Wassberg C; Thörn M; Yuen J; Ringborg U; Hakulinen T
Br J Cancer; 1996 Jan; 73(2):255-9. PubMed ID: 8546916
[TBL] [Abstract][Full Text] [Related]
30. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study.
Franceschi S; Dal Maso L; Arniani S; Crosignani P; Vercelli M; Simonato L; Falcini F; Zanetti R; Barchielli A; Serraino D; Rezza G
Br J Cancer; 1998 Oct; 78(7):966-70. PubMed ID: 9764592
[TBL] [Abstract][Full Text] [Related]
31. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
32. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
[TBL] [Abstract][Full Text] [Related]
33. Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
[TBL] [Abstract][Full Text] [Related]
34. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
35. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
36. The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.
Li H; Pedersen L; Nørgaard M; Ulrichsen SP; Thygesen SK; Nelson JJ
BMC Cancer; 2016 May; 16():295. PubMed ID: 27141983
[TBL] [Abstract][Full Text] [Related]
37. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study.
Koljonen V; Kukko H; Tukiainen E; Böhling T; Sankila R; Joensuu H; Pukkala E
Cancer Epidemiol; 2010 Feb; 34(1):62-5. PubMed ID: 20061203
[TBL] [Abstract][Full Text] [Related]
38. Incidence of second sarcomas: a cancer registry-based study.
Levi F; Randimbison L; Maspoli-Conconi M; Blanc-Moya R; La Vecchia C
Cancer Causes Control; 2014 Apr; 25(4):473-7. PubMed ID: 24463790
[TBL] [Abstract][Full Text] [Related]
39. Skin cancer in survivors of childhood and adolescent cancer.
Levi F; Moeckli R; Randimbison L; Te VC; Maspoli M; La Vecchia C
Eur J Cancer; 2006 Mar; 42(5):656-9. PubMed ID: 16442793
[TBL] [Abstract][Full Text] [Related]
40. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
Hemminki K; Jiang Y; Steineck G
Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]